Publication date: Jun 23, 2025
Tuberculosis (TB) and diabetes mellitus comorbidity can lead to poor TB treatment outcomes, particularly with uncontrolled blood glucose levels. Understanding the impact of glycemic control on TB treatment outcomes is essential. To synthesise evidence on the association between glycemic control and TB treatment outcomes in patients with TB and diabetes mellitus. A systematic review was conducted using Medline, Embase, Scopus, Web of Science, Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Google Scholar for all types of studies published between 1975 and May 2024, including adult TB patients of >18 years of age, with or without diabetes mellitus for whom blood glucose testing along with TB treatment outcome comparison with glucose levels (low/high) was reported were considered for inclusion. A random-effects model was used for meta-analysis, heterogeneity was assessed using I-squared statistics, subgroup and sensitivity analysis was performed followed by publication bias assessment. Of 576 identified studies, 12 met the inclusion criteria, analysing 2320 cases (1572 with uncontrolled high blood glucose [≥7% HbA1c] and 748 with controlled low blood glucose [
| Concepts | Keywords |
|---|---|
| Bias | blood glucose |
| Diabetes | diabetes |
| glycaemic control | |
| Medline | treatment failure |
| tuberculosis |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | tuberculosis |
| pathway | KEGG | Tuberculosis |
| disease | MESH | diabetes mellitus |
| disease | MESH | comorbidity |
| drug | DRUGBANK | Dextrose unspecified form |
| drug | DRUGBANK | Methionine |
| disease | MESH | treatment failure |